Many have gone over and seen the glowing Afrezza reviews thus far on WebMD. For anyone who has doubts about Type 2's acceptance of Afrezza, check out the reviews on Metformin. They will blow your (not your mind).Star ratings, 3 Effectiveness, 4 Ease of Use (its a pill) and 3 Satisfaction. Afrezza is running 5's across the board. Have patience as the patients will come, in droves for Afrezza
During Hockey Games,on Airplanes or in your lazy boy at home. Afreeza eliminates any discomfort, hesitation, reluctance, stigma, inconvenience, or excuse of any kind to not be compliant with your diabetes care during meals. That my friends IS the money shot. Once insurers realize this, Afreeza moves to tier 2 on the formulary.
a thumbs down. Ignore them and their many aliases entirely. The silence will be deafening for them. They are like brat children whining for attention. Treat them as you would treat those brats.
they don't even have to worry about sales. That's Sanofi's lift. MNKD needs to focus on production and the next technosphere application
Why the TRx numbers will ramp up slowly;
"You had to be aware of Afrezza. You had to want Afrezza. You had to schedule an appointment with your physician to get a script. You have to present the script at the pharmacy. The pharmacy, in all likelihood had to order Afrezza resulting in an additional day delay. The script counts when the script is filled. Patience, we're not going to reach 10,000 TRx overnight. But down the road we will substantially exceed that number. IMHO
Ha! That's hysterical. If they keep posting on webmd at that rate I predict their server crashes by year end.
Thank You slugobear. coldly rational is the appropriate way to invest. I am not a scientist, but a negotiator. One needs to know with as much certainty as they possibly can ascertain what the probabilities are for the outcome they seek. In MNKD, I found, what I believe you found, after much DD, a major disruption to the status quo. That is why I selected MNKD. I'm fully loaded as well. I am not a cultist and am not married to this stock as shorts would like us to believe. I am "coldly rational". All the best.
Agreed. Let's consider the "14". You had to be aware of afrezza. You had to want afrezza. You had to schedule an appointment with your physician to get a script. You have to present the script at the pharmacy. The pharmacy, in all likelihood had to order afrezza resulting in an additional day delay. The script counts when the script is filled. Patience, we're not going to reach 10,000 TRx overnight. But down the road we will substantially exceed that number. IMHO
Sentiment: Strong Buy
Interesting, all RAA rx's are down. How can this be as these are needed maintenance medications? Is it do to some diabetics trialing the Afrezza samples before renewing their injectable RAA scripts? Its a puzzlement. Whatever, we really won't see much movement until the additional lines are producing at Danbury and Direct to Consumer Advertizing begins. Until then, patience.